• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受维持性6-巯基嘌呤治疗的克罗恩病患者外周血白细胞DNA中6-硫鸟嘌呤的定量分析。

Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy.

作者信息

Cuffari C, Seidman E G, Latour S, Théorêt Y

机构信息

Department of Pediatrics, Hôpital Sainte-Justine, Université de Montréal, QC, Canada.

出版信息

Can J Physiol Pharmacol. 1996 May;74(5):580-5.

PMID:8884023
Abstract

The effects of 6-mercaptopurine (6MP) in inflammatory bowel disease are believed to be primarily mediated by its metabolite 6-thioguanine (6TG). Our aim was to develop an assay for measuring leukocyte DNA 6TG levels in patients with Crohn's disease, and to correlate them with levels of 6TG in erythrocytes. Heparinized blood was obtained from 15 adolescent Crohn's disease patients receiving 6MP at an average dose of 1.3 mg.kg-1 day-1 (range 0.8-1.6 mg.kg-1 day-1) for a mean of 23.7 months (range 3-71 months). Leukocyte DNA and erythrocyte 6TG levels were measured by an HPLC assay. Leukocyte 6TG levels ranged from 100 to 2305 pmol/mg DNA, while erythrocyte 6TG levels ranged from 64 to 1038 pmol/8 x 10(8) red blood cells, demonstrating significant interpatient variability. Leukocyte DNA 6TG levels correlated directly with erythrocyte 6TG levels, as measured by the Spearman rank correlation coefficient (p < 0.05). The HPLC measurement of erythrocyte and leukocyte DNA 6TG levels can be useful clinically in monitoring compliance, as well as perhaps to tailor drug metabolite levels to achieve the desired clinical effect.

摘要

6-巯基嘌呤(6MP)在炎症性肠病中的作用被认为主要是由其代谢产物6-硫鸟嘌呤(6TG)介导的。我们的目的是开发一种检测克罗恩病患者白细胞DNA中6TG水平的方法,并将其与红细胞中6TG水平相关联。从15名接受6MP治疗的青少年克罗恩病患者中获取肝素化血液,这些患者的平均剂量为1.3mg·kg-1·天-1(范围为0.8 - 1.6mg·kg-1·天-1),平均治疗时间为23.7个月(范围为3 - 71个月)。通过高效液相色谱法(HPLC)检测白细胞DNA和红细胞6TG水平。白细胞6TG水平范围为100至2305pmol/mg DNA,而红细胞6TG水平范围为64至1038pmol/8×10⁸个红细胞,表明患者间存在显著差异。通过Spearman等级相关系数测量,白细胞DNA 6TG水平与红细胞6TG水平直接相关(p < 0.05)。红细胞和白细胞DNA 6TG水平的HPLC测量在临床上可用于监测依从性,也可能有助于调整药物代谢产物水平以达到预期的临床效果。

相似文献

1
Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy.接受维持性6-巯基嘌呤治疗的克罗恩病患者外周血白细胞DNA中6-硫鸟嘌呤的定量分析。
Can J Physiol Pharmacol. 1996 May;74(5):580-5.
2
Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.监测日本炎症性肠病患者的6-硫鸟嘌呤核苷酸浓度。
J Gastroenterol Hepatol. 2008 Sep;23(9):1373-7. doi: 10.1111/j.1440-1746.2008.05419.x. Epub 2008 Jul 23.
3
6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.接受硫唑嘌呤治疗的炎症性肠病类固醇依赖患者的6-硫鸟嘌呤监测
Aliment Pharmacol Ther. 2005 Apr 1;21(7):829-39. doi: 10.1111/j.1365-2036.2005.02419.x.
4
Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy.对接受基于6-巯基嘌呤维持治疗的患者外周血白细胞DNA中6-硫鸟嘌呤残基的定量分析。
Cancer Res. 1995 Apr 15;55(8):1670-4.
5
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.硫鸟嘌呤核苷酸不能预测硫鸟嘌呤在克罗恩病中的疗效。
Aliment Pharmacol Ther. 2004 Jun 15;19(12):1269-76. doi: 10.1111/j.1365-2036.2004.01947.x.
6
Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.接受6-硫鸟嘌呤与6-巯基嘌呤治疗的急性淋巴细胞白血病患儿中硫嘌呤类药物的药代动力学和代谢情况。
Cancer Chemother Pharmacol. 1998;42(4):266-72. doi: 10.1007/s002800050816.
7
The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.6-硫鸟嘌呤代谢物水平在炎症性肠病患者管理中的效用。
Am J Gastroenterol. 2004 Sep;99(9):1744-8. doi: 10.1111/j.1572-0241.2004.30415.x.
8
6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.克罗恩病中6-巯基嘌呤的代谢:与疗效和毒性的相关性
Gut. 1996 Sep;39(3):401-6. doi: 10.1136/gut.39.3.401.
9
Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia.红细胞中硫嘌呤核苷酸的定量分析及其在儿童急性淋巴细胞白血病中的临床应用
Ther Drug Monit. 2019 Feb;41(1):75-85. doi: 10.1097/FTD.0000000000000575.
10
Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.在克罗恩病免疫调节的6-硫鸟嘌呤治疗期间进行的硫嘌呤代谢物扩展评估。
J Clin Pharmacol. 2007 Feb;47(2):187-91. doi: 10.1177/0091270006294403.

引用本文的文献

1
Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers.对克罗恩病患者进行DNA-硫鸟嘌呤的早期主动监测可预测NUDT15/TPMT正常代谢者硫嘌呤诱导的迟发性白细胞减少症。
World J Gastroenterol. 2024 Mar 28;30(12):1751-1763. doi: 10.3748/wjg.v30.i12.1751.
2
Development of innovative methodology for determination of 6-thioguanine in whole blood erythrocytes by HPLC-PDA-based technique for medical diagnostics purposes.建立基于 HPLC-PDA 技术的创新方法,用于测定全血红细胞中的 6-硫鸟嘌呤,以用于医学诊断目的。
Sci Rep. 2023 Aug 29;13(1):14172. doi: 10.1038/s41598-023-41426-5.
3
Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis.
高效液相色谱法检测红细胞中 6-巯基嘌呤代谢物的改进:监测数据和文献分析。
Int J Mol Sci. 2022 Oct 6;23(19):11885. doi: 10.3390/ijms231911885.
4
Pharmacogenetics of thiopurines.硫唑嘌呤的药物遗传学
Cancer Drug Resist. 2019 Jun 19;2(2):256-270. doi: 10.20517/cdr.2019.004. eCollection 2019.
5
New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer small molecule potentiators.评估6-硫代嘌呤毒性并将其治疗应用扩展至胰腺癌的新方法——小分子增强剂。
Medchemcomm. 2019 Mar 18;10(5):717-725. doi: 10.1039/c9md00010k. eCollection 2019 May 1.
6
Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.美沙拉嗪和硫唑嘌呤调节连接复合体,恢复肠道炎症中的上皮屏障功能。
Sci Rep. 2019 Feb 26;9(1):2842. doi: 10.1038/s41598-019-39401-0.
7
Efforts in redesigning the antileukemic drug 6-thiopurine: decreasing toxic side effects while maintaining efficacy.重新设计抗白血病药物6-硫嘌呤的努力:在保持疗效的同时降低毒副作用。
Medchemcomm. 2018 Dec 20;10(1):169-179. doi: 10.1039/c8md00463c. eCollection 2019 Jan 1.
8
Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease.炎症性肠病患者硫嘌呤类药物治疗药物监测的分析陷阱
Ther Drug Monit. 2017 Dec;39(6):584-588. doi: 10.1097/FTD.0000000000000455.
9
Excited-State Dynamics of the Thiopurine Prodrug 6-Thioguanine: Can N9-Glycosylation Affect Its Phototoxic Activity?硫嘌呤前药6-硫鸟嘌呤的激发态动力学:N9-糖基化会影响其光毒性活性吗?
Molecules. 2017 Feb 28;22(3):379. doi: 10.3390/molecules22030379.
10
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients.液相色谱-质谱联用技术用于测定硫嘌呤治疗患者DNA中的脱氧硫鸟苷。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:175-180. doi: 10.1016/j.jchromb.2016.06.017. Epub 2016 Jun 15.